Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
about
Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factorsGenomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoformSemaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effectIdentification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activityAntiangiogenic Steroids in Human Cancer Therapy.NRP1 function and targeting in neurovascular development and eye diseaseStructural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic formsDirect interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cellsNeuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesisVascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotypeMolecular mapping and functional characterization of the VEGF164 heparin-binding domainVEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasmVEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vesselsVascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinaseA peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cellsA compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trapTargeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches.Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival.Targetting VEGF in anti-angiogenic and anti-tumour therapy: where are we now?Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis.Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.Factors promoting tumor angiogenesis.VEGF in the lung: a role for novel isoformsVascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.ZIP4 upregulates the expression of neuropilin-1, vascular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenograftsNucleophosmin is recognized by a cytotoxic T cell line derived from a rectal carcinoma patient.Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesisNeuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafishNeuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.Regulation of retinal axon growth by secreted Vax1 homeodomain protein.Fast rearrangement of the neuronal growth cone's actin cytoskeleton following VEGF stimulation.Semaphorin 5A mediated cellular navigation: connecting nervous system and cancerRegulation of microvascular permeability by vascular endothelial growth factors.Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significanceMicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expressionCharacterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars.Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.Structural basis for VEGF-C binding to neuropilin-2 and sequestration by a soluble splice form.Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions.
P2860
Q24305041-FDC70227-6AAD-4E63-9884-A49C9A66531DQ24311517-13FA28A7-5973-4314-8CB3-2179E5464759Q24564247-8FEC7B91-2147-4CD6-AE2D-56A6DFD16E35Q24677555-3273B46A-A38A-4A74-A978-D2F4C26CBBCAQ24795360-E9EA2C71-DB23-4102-8AA6-5EB34CB62D78Q26765952-A954D84F-007C-4A87-8DC8-658AA08BB163Q27677161-CC50879D-6564-4ED8-B375-D5FC879A6338Q28141270-0382390E-7250-489B-89AD-8AACFA12893DQ28210850-2BB51D90-7D94-40CC-9558-9372008F9AD0Q28263245-9C72AF28-0F26-4CC8-8E6F-EF744A859131Q28345309-EEF18B39-4F94-486C-BE4F-94E74632C0CCQ28505465-2593D52B-2DB6-4973-BB44-63686A234FBFQ28587818-53079F7A-F98B-41B5-ABFD-1730A3C29384Q28593860-0EBBB12F-676F-41A7-8A89-113E1DAE6B8FQ28646403-5D41C7F7-582C-47F1-9968-D8F37D9A1587Q29543360-9397D113-EEE6-4012-BFC8-82CE45EBDA79Q30439884-5E61C174-9BE0-47E9-97CC-2648247B3D29Q33267903-D036B2BA-AB1D-4335-989E-C6EC5C7360C8Q33305429-E3D61DB5-46E6-4504-86E6-51DA49C4D4E3Q33630409-E461561A-FE77-4B83-9304-35D5377E0966Q33640220-D27E19B4-AA08-4397-95C2-E2A9B20BA9F1Q33737131-98035C6F-0446-4B5D-834C-934ED9BAE135Q33791689-E73991CC-F1CE-42A4-80CD-B2647F7F1598Q33916926-9A56CBC1-B750-45A7-97A3-4E3CF7BA4D41Q33940345-C5B5855E-9EC0-4556-907C-CAD4EC316B17Q33959544-3BCE58E9-0D23-4509-B8C2-5B4A05110095Q33965222-3412C9F3-E6C0-45A7-B95C-077D57E4BCE6Q34019593-2E8784D8-DBF0-4B42-8F55-997CB1BFC6BAQ34074705-B84FF184-BB6E-4614-B1F7-C8D5F3D429AEQ34147572-E1A292B3-BCF7-4906-93AC-C52A6DD3F02FQ34437491-540F0278-AFE7-4AB9-B14C-CBB855A5A1FFQ34439734-E67D27A4-242A-4E67-B179-19DEFC82AD13Q34663792-238912BE-F2BC-4E57-A6CE-CF1C90969F85Q34774011-8EBFB325-3679-4AEF-AD7E-8512DBC8780BQ34785969-6C72BA4B-91F4-4CD2-B8F9-4A9488965D7FQ35149147-ACD195BB-9D51-4BBB-923D-D85008EBC694Q35206904-0490D5F5-63CE-4615-940A-97407AF2ABCDQ35279932-CC8DEC2C-BF77-4869-AC80-4FA442D5DFB3Q35374781-27131FED-BF35-4355-9789-2C07B78AE2C0Q35534079-3939AF39-7D2F-4573-9AB8-2856F3B2F65C
P2860
Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Characterization of novel vasc ...... via its exon 7-encoded domain.
@en
type
label
Characterization of novel vasc ...... via its exon 7-encoded domain.
@en
prefLabel
Characterization of novel vasc ...... via its exon 7-encoded domain.
@en
P2093
P356
P1476
Characterization of novel vasc ...... via its exon 7-encoded domain.
@en
P2093
P304
P356
10.1074/JBC.271.10.5761
P407
P577
1996-03-01T00:00:00Z